News
55m
Unblinded safety data from Phase 2b QUALITY study expected in the second quarter of calendar 2025 -- --Topline efficacy and safety data for Phase 2b extension maintenance study expected in the second ...
55m
Announced positive top-line results from Phase 2 CIRRUS-HCM trial of EDG-7500 in Hypertrophic Cardiomyopathy (HCM) - - Strengthened balance sheet with net proceeds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback